公司概覽
業務類別 Biotechnology
業務概覽 Mesoblast Ltd is a commercial-stage biotechnology company and a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. The company's product candidates include: Ryoncil (remestemcel-L) for the treatment of steroid-refractory acute graft versus host disease, as well as for the treatment of moderate to severe acute respiratory distress syndrome; Revascor (rexlemestrocel-L) for the treatment of chronic heart failure; and Rexlemestrocel-L for chronic low back pain. The company is managed as one operating segment, being the development of an adult stem cell technology platform for commercialization.
公司地址 55 Collins Street, Level 38, Melbourne, VIC, AUS, 3000
電話號碼 +61 396396036
傳真號碼 +61 396396030
公司網頁 https://www.mesoblast.com
員工數量 81
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Paul Hughes, B.Bus Joint Company Secretary -- 29/08/2025
Dr. Eric A. Rose, M.D. Director and Chief Medical Officer 澳元 701.84K 29/08/2025
Mr. Peter Howard, B.Sc. ,L.L.B. Group General Counsel -- 29/08/2025
Ms. Niva Sivakumar, B.Com,L.L.B. Joint Company Secretary -- 29/08/2025
Dr. Silviu Itescu, F.A.C.P.,F.R.A.C.P. Director and Chief Executive Officer 澳元 757.50K 29/08/2025
Mr. Michael Schuster, M.B.A. Pharma Partnering -- 29/08/2025
Dr. Paul Simmons, PhD Scientific Advisor to the Chief Executive Officer -- 29/08/2025
Ms. Geraldine Storton, B.Sc. ,M.B.A. Head of Regulatory Affairs and Quality Management -- 29/08/2025
Mr. Andrew Chaponnel, B.Com Interim Chief Financial Officer -- 29/08/2025
Mr. Justin Horst, B.S. Head of Manufacturing -- 29/08/2025
Dr. Fiona See, PhD Senior Vice President and Head of Translational Research -- 29/08/2025
 
董事會成員
董事會 職務 更新日期
Dr. Eric A. Rose, M.D. Director and Chief Medical Officer 29/08/2025
Mr. Joseph R. Swedish, M.H.A Independent Director 29/08/2025
Ms. Lyn Cobley, BEc Independent Director 29/08/2025
Mr. William J. Burns, B.A. Vice Chairman of the Board 29/08/2025
Mr. Philip J. Facchina Independent Director 29/08/2025
Dr. Silviu Itescu, F.A.C.P.,F.R.A.C.P. Director and Chief Executive Officer 29/08/2025
Ms. Jane Bell, L.L.B.,L.L.M. Chairman of the Board 29/08/2025
Dr. Gregory George, M.D. Director 29/08/2025
Mr. Philip Krause, M.D. Director 29/08/2025
 
所屬ETF (更新日期: 07/03/2026 02:11)
代號 名稱 佔比% 持有日期
IBBiShares Biotechnology ETF0.40%28/02/2026
APIEActivePassive International Equity ETF0.003%27/02/2026
IBBQInvesco Nasdaq Biotechnology ETF0.002%27/02/2026
BIBProShares Ultra Nasdaq Biotechnology0.002%27/02/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.